Message #10 From:
NewsBot Date: March 12, 2008 01:22:12 PM
Hathaway (HWYI) Enters Into LOI With Korean Medical Device Manufacturer, U & I Bio-Tech, Inc.
Revolutionary Non-Invasive Medical Diagnostic Device Holds Huge Marketing Potential
Hathaway Corporation (PINKSHEETS: HWYI), a company that focuses on acquiring, developing, and managing
disruptive technologies in the telecommunications, medical devices, and
software fields that change the way companies grow and service their
businesses globally, announced that the Company has entered into a Letter
of Intent for a joint venture with U&I Bio-Tech, Inc., a South Korea-based
Medical Device Company, for BioHarp, a unique diagnostic medical device
currently in development by U&I. BioHarp's revolutionary patented
technology will provide physicians with the capability to diagnose a
variety of ailments quickly, accurately, and in a totally safe and
non-invasive manner.
"We are very excited about adding the BioHarp product line, with its
massive worldwide marketing potential, to Hathaway's group of companies. A
medical device that can assist physicians in diagnosing physical ailments
non-invasively is truly remarkable and further illustrates our commitment
to finding disruptive technologies. Our experience in this area makes this
project a great fit. We are also particularly looking forward to working
with the impressive team at U&I Bio-Tech," stated Mr. Paul D. Lisenby, CEO
of Hathaway. "We have already commenced our due diligence, which will
include exploring different market segments for BioHarp, as well as
regulatory clearance in various countries, such as the FDA in the US. Once
all our parameters are met, we plan to close the deal in 45-60 days."
About Hathaway
Hathaway Global Inc. focuses on acquiring disruptive technologies in the
telecommunications, medical devices, and software fields that can change or
alter the way companies grow and service their businesses globally.
Hathaway provides financial and infrastructural support to create revenue
growth companies, positioning them to leverage the opportunities such
technologies are typically capable of. Hathaway then offers the company on
the public market or facilitates a buyout. Through companies like OptiCon,
Hathaway brings the communication solutions of the future to today's
business marketplace. To request further information about Hathaway, please
email us at investors@hathawayglobal.com
Forward-Looking Statements
This press release may contain forward-looking statements covered within
the meaning of the Private Securities Litigation Reform Act of 1995. These
forward-looking statements relate to, among other things, plans and timing
for the introduction or enhancement of our services and products,
statements about future market conditions, supply and demand conditions,
and other expectations, intentions and plans contained in this press
release that are not historical fact and involve risks and uncertainties.
Our expectations regarding future revenues depend upon our ability to
develop and supply products and services that we may not produce today and
that meet defined specifications. When used in this press release, the
words "plan," "expect," "believe," and similar expressions generally
identify forward-looking statements. These statements reflect our current
expectations. They are subject to a number of risks and uncertainties,
including, but not limited to, changes in technology and changes in
pervasive markets.
Contact:
FutureTechIR for Hathaway Corporation
Investor Relations
(817) 812-2105
